Increased detection of NRG1 fusions in non-squamous non–small cell lung cancer using combined DNA and RNA sequencing in a real-world cohort
- 10 March 2026
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 215, 109370
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comprehensive identification of NRG1 fusions in 25,203 patients with solid tumorsnpj Precision Oncology, 2025
- Efficacy of Zenocutuzumab in NRG1 Fusion–Positive CancerNew England Journal of Medicine, 2025
- RNA Sequencing Identifies Novel NRG1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic DriversThe Journal of Molecular Diagnostics, 2023
- Rare molecular subtypes of lung cancerNature Reviews Clinical Oncology, 2023
- Clinicopathologic Features and Response to Therapy ofNRG1Fusion–Driven Lung Cancers: The eNRGy1 Global Multicenter RegistryJournal of Clinical Oncology, 2021
- Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American PopulationsCancer Discovery, 2021
- NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agentsAnnals of Oncology, 2020
- Detection of NRG1 Gene Fusions in Solid TumorsClinical Cancer Research, 2019
- AACR Project GENIE: Powering Precision Medicine through an International ConsortiumCancer Discovery, 2017
- Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lungOncotarget, 2016